Clinical Trial Update: Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on sublingual immunotherapy for peanut allergy with induction of tolerance. Completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Peanut Hypersensitivity, Food Hypersensitivity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-12